Endo International plc $67.62

up +0.54


1/8/2014 04:00 PM  |  NASDAQ : ENDP  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get ENDP Trend Analysis - it has outperformed the S&P 500 by 60%

Partner Headlines

  1. Endo's Paladin Labs Reports Canadian Introduction Of Veregen

    Benzinga
  2. Stock Futures Sag Early Monday; King Digital Leans Higher

    IBD
  3. Benzinga's M&A Chatter for Tuesday June 24, 2014

    Benzinga
  4. Wells Fargo Initiates Coverage On The Pharmaceutical Space

    Benzinga
  5. UPDATE: Morgan Stanley Upgrades Endo International PLC On Attractive Risk-Reward

    Benzinga
  6. Endo profit tops despite charge

    IBD
  7. Sterne Agee Sees Good Things Ahead for Endo International PLC

    Benzinga
  8. Earnings Scheduled For May 1, 2014

    Benzinga
  9. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD
  10. Endo Reaches $830M Settlement on Majority of AMS Litigation Cases

    Benzinga
  11. Actavis Q1 Earnings Beat On Generic Cymbalta Surprise

    IBD
  12. Endo to Acquire Grupo Farmaceutico, No Terms Disclosed

    Benzinga
  13. Morning Market Movers

    Benzinga
  14. Benzinga's Top #PreMarket Gainers

    Benzinga
  15. Zogenix Announces Sale of SUMAVEL DosePro Migraine Therapy to Endo International ...

    Benzinga
  16. Forest Laboratories Is an Option for Wealthy Investors Who Could Afford ...

    GuruFocus
  17. Mylan Says Judge Has Enforced Settlement Deal Between Mylan, Endo Related ...

    Benzinga
  18. Morgan Stanley Sees Possible Upside Source for Endo International PLC

    Benzinga
  19. Ampio Pharmaceuticals' Vyrix Enters into an Agreement with Paladin Labs ...

    Benzinga
  20. Meda Rejects Mylan's Bid

    IBD
  21. Mylan Rejected In Bid To Acquire Sweden's Meda

    IBD
  22. Market Wrap For March 6: Investors Find Positives In Jobless Claims

    Benzinga
  23. Morgan Stanley Updates Estimates On Endo Health Solutions

    Benzinga
  24. Market Wrap For February 28: Markets Unable To Hold On To Gains

    Benzinga
  25. Earnings Scheduled For February 28, 2014

    Benzinga
  26. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  27. Stocks End Higher; MercadoLibre Jumps After Hours

    IBD
  28. Actavis Q4 Beats Street; Guidance Affirmed For Now

    IBD
  29. Endo Confirms Court Upholds FROVA Patent

    Benzinga
  30. Top Gainers After Hours

    Benzinga
  31. UPDATE: Endo and BioDelivery Sciences Announce Positive Top-Line Results ...

    Benzinga
  32. Benzinga's M&A Chatter for Tuesday January 21, 2014

    Benzinga
  33. Drug Mergers Queuing Up

    IBD
  34. Stocks End Mixed; Macy's Up After Hours, To Cut Jobs

    IBD
  35. Market Wrap For January 8: Fed Minutes Released

    Benzinga
  36. Stocks Mixed As Chips Buoy Nasdaq; Endo Health Breaks Out

    IBD
  37. Forest Buying Aptalis; Teva Bids For NuPathe Vs. Endo

    IBD
  38. Endo Health Solutions

    IBD
  39. Stocks Near Day's Lows; SunPower Heats Up

    IBD
  40. Endo Health Downgraded On Weak Zecuity Outlook

    IBD
  41. Endo Announces Early Termination of HSR Act Waiting Period in Connection ...

    Benzinga
  42. Benzinga's M&A Chatter for Monday December 16, 2013

    Benzinga
  43. Merger Monday Lives Up To Its Name: 33.175 Billion In Deals

    Benzinga
  44. Morning Market Movers

    Benzinga
  45. Endo to Acquire NuPathe for $2.85/Share in Cash

    Benzinga
  46. UPDATE: Citigroup Reiterates on Endo Health Solutions on Potential of Paladin ...

    Benzinga
  47. Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  48. UPDATE: Piper Jaffray Upgrades Endo Health Solutions as Paladin Transaction ...

    Benzinga
  49. Benzinga's Top Upgrades

    Benzinga
  50. Benzinga's M&A Chatter for Tuesday November 5, 2013

    Benzinga
Trading Center